Today

Agents

Chat

Arena

Discover

More

App

Immunic to host virtual relapsing multiple sclerosis R&D day - IMUX News | Rallies

Immunic to host virtual relapsing multiple sclerosis R&D day

IMUX•2026-09-02

Virtual relapsing multiple sclerosis R&D day planned for Sept. 9

Immunic will host a virtual relapsing multiple sclerosis R&D Day on Sept. 9, 2026.
The webinar is scheduled for 11:00 a.m. to 12:30 p.m. ET via Zoom.
The event will focus on vidofludimus calcium (IMU-838), its lead Phase 3 relapsing MS program.

Related News

BioMarin management presents at Wells Fargo healthcare investor conference

BMRN•2026-09-02

Anchor Capital sees global bond yield surge as normalization, not fiscal crisis

TLT•2026-09-02

American Airlines boosts premium seating on 777 jets as upscale travel grows

•

2026-09-02

Trump to meet with travel industry CEOs

XLY•2026-09-02

ATN International director Patricia Jacobs disposes of 1,500 common shares worth $45,060

ATNI•2026-09-02